Oslo University Hospital Ullevaal, Department of Pulmonary Medicine
Oslo, 0407, Norway
NCT Number: NCT01019538
The purpose of this study is to evaluate if supplemental oxygen during air travel can be reliably titrated using a Hypoxia-altitude simulation test (HAST). Also, the effect of oxygen supplementation given with the various oxygen equipment allowed for air travel is studied.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Oslo, 0407, Norway
International guidelines recommend supplemental oxygen if PaO2 < 6.7 kPa (50 mmHg) during air travel. Hypobaric chamber exposure is the ideal test but is not widely available. In clinical practice, the HAST has been recommended as the preferable test for pre-flight evaluation, and is used with increasing frequency. The oxygen dose during air travel has been recommended titrated during HAST. In the study, supplemental oxygen titration during hypobaric chamber exposure is compared to oxygen titration during HAST, to evaluate if HAST can be used with confidence to titrate the amount of supplemental oxygen needed during air travel.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Hypoxia-altitude simulation test, which is established in clinical practice, is compared to the gold standard of hypobaric chamber while giving supplemental gaseous oxygen without and with oxygen conserving device, and with oxygen concentrator.
Other names: Oxygen
Time frame: 1 day
Ullevaal University Hospital
Other
COPD and Air Travel: Oxygen Equipment and Pre-flight Titration of Supplemental Oxygen
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108925
Chronic Disease, Chronic Obstructive Pulmonary Disease
Hakadal, Akershus, Norway
View Trial DetailsNCT00740220
Anoxia, Chronic Disease
Winston-Salem, North Carolina, United States
View Trial DetailsNCT00896584
Chronic Disease, Chronic Obstructive Pulmonary Disease
Hakadal, Norway
View Trial DetailsNCT07512687
Chronic Disease, Chronic Obstructive Pulmonary Disease
Buffalo, New York, United States
View Trial Details